急性呼吸器不全における病棟ベースの高流量鼻酸素療法 - 長期的な死亡率の遡及的分析
Respiration; international review of thoracic diseases
|August 28, 2025
まとめ
急性呼吸器不全 (ARF) の呼吸病棟での高流量鼻酸素療法 (HFNO) は,診断によって同様の長期死亡率を示した. 麻痺治療 (DNI) 命令と麻痺治療の設定は死亡率の増加と関連していました.
科学分野:
- 肺科
- クリティカル ケア 医療
- 内科 医学
背景:
- 高フロー鼻酸素療法 (HFNO) は,急性呼吸器不全 (ARF) に関して,集中治療室 (ICU) 以外の呼吸器病棟 (RW) でますます使用されています.
- この環境でHFNOの使用による入院,短期および長期の死亡率に関するデータは限られている.
研究 の 目的:
- 呼吸器科でHFNOで治療されたARF患者の入院,短期および長期の死亡率を評価する.
- この患者集団における死亡率に関連する要因を特定する.
主な方法:
- 2020年1月から2022年9月までのRWでHFNOを投与された16歳以上の患者の遡及分析.
- 患者は,主診断とインチューブしない状態 (DNI) によってグループ化されました.
- 死亡率の分析にはコックス比例リスクモデルを使用した.
主要な成果:
- 145人のARF患者 (平均年齢70歳) が分析され,主にCOVID-19による (57.9%) であった.
- 入院死亡率は24.8%で,30日,90日,1年の死亡率はそれぞれ30%,38%,43%であった.
- 長期死亡率は診断群によって有意な差異はなかった. 高いBMIは死亡率の低下と関連していたが,DNI命令と緩和療法の設定は死亡率の上昇と関連していた.
結論:
- ARFの基礎診断は,RWでHFNOで治療された患者の死亡リスクに有意な影響を及ぼさなかった.
- RWのHFNOは,入院しない患者のための高度なケアを提供し,潜在的にICUのリソースの負担を軽減することができます.
関連する概念動画
Acute Respiratory Failure-V
203
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
203
Acute Respiratory Failure-I
320
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
320
Respiratory Assessment: Purpose and Indications
1.2K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.2K
Acute Respiratory Failure-II
357
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
357
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
317
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
317
Acute Respiratory Failure-IV
227
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
227


